News

Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Kenvue Inc. stock falls Tuesday, underperforms market
The stock's fall snapped a four-day winning streak.
6KVUE : Assessing Kenvue: Insights From 6 Financial Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...
Barchart on MSN1d
Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?
Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to ...
Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is ...
Kenvue Inc. (KVUE) Has “Good Brands,” Says Jim Cramer
We recently published 10 Stocks Jim Cramer Discussed As He Commented On Latest Tariffs. Kenvue Inc. (NYSE:KVUE) is one of the ...
Explore more
Stock Movers: Coinbase, Kenvue, Synopsis
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...